A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women
Public ClinicalTrials.gov record NCT01252186. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multinational, Multicenter, Randomized, Open-Label Study to Evaluate the Impact of a 91-Day Extended Cycle Oral Contraceptive Regimen, Compared to Two 28-day Standard Oral Contraceptive Regimens, on Hemostatic Parameters in Healthy Women.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is being conducted to evaluate the impact of a 91-day extended cycle oral contraceptive compared to two 28-day oral contraceptive regimens on hemostatic parameters in healthy women.
Study identification
- NCT ID
- NCT01252186
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 265 participants
Conditions and interventions
Conditions
Interventions
- 91-day Levonorgestrel Oral Contraceptive Drug
- 28-day Levonorgestrel Oral Contraceptive Drug
- 28-day Desogestrel Oral Contraceptive Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 40 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2010
- Primary completion
- Nov 30, 2011
- Completion
- Nov 30, 2011
- Last update posted
- Mar 12, 2015
2010 – 2011
United States locations
- U.S. sites
- 21
- U.S. states
- 12
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site | San Diego | California | 92103 | — |
| Teva Investigational Site | San Diego | California | 92108 | — |
| Teva Investigational Site | San Diego | California | 92123 | — |
| Teva Investigational Site | Washington D.C. | District of Columbia | 20036 | — |
| Teva Investigational Site | Miami | Florida | 33186 | — |
| Teva Investigational Site | West Palm Beach | Florida | 33409 | — |
| Teva Investigational Site | Sandy Springs | Georgia | 30328 | — |
| Teva Investigational Site | Edison | New Jersey | 08817 | — |
| Teva Investigational Site | Plainsboro | New Jersey | 08536 | — |
| Teva Investigational Site | Albuquerque | New Mexico | 87102 | — |
| Teva Investigational Site | Port Jefferson | New York | 11777 | — |
| Teva Investigational Site | Rochester | New York | 14609 | — |
| Teva Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Teva Investigational Site | Philadelphia | Pennsylvania | 19114 | — |
| Teva Investigational Site | Pittsburgh | Pennsylvania | 15206 | — |
| Teva Investigational Site | Uniontown | Pennsylvania | 15401 | — |
| Teva Investigational Site | Dallas | Texas | 75234 | — |
| Teva Investigational Site | Houston | Texas | 77054 | — |
| Teva Investigational Site | San Antonio | Texas | 78258 | — |
| Teva Investigational Site | Richmond | Virginia | 23233 | — |
| Teva Investigational Site | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01252186, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 12, 2015 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01252186 live on ClinicalTrials.gov.